BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 20233288)

  • 1. Sexuality and management of benign prostatic hyperplasia with alfuzosin: SAMBA Thailand.
    Leungwattanakij S; Watanachote D; Noppakulsatit P; Petchpaibuol T; Choeypunt N; Tongbai T; Wanamkang T; Lojanapiwat B; Permpongkosol S; Tantiwong A; Pripatnanont C; Akarasakul D; Kongwiwatanakul S; Chotikawanich E
    J Sex Med; 2010 Sep; 7(9):3115-26. PubMed ID: 20233288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with a uroselective α1-blocker improves voiding and sexual function: a study in Thai men with lower urinary tract symptoms.
    Permpongkosol S; Krilad-O-Larn S; Ratana-O-Larn K
    J Sex Med; 2011 Sep; 8(9):2582-9. PubMed ID: 21699664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
    Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
    BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of alfuzosin 10 mg once daily on quality of life in Tunisian patients with lower urinary symptoms suggestive of benign prostatic hyperplasia].
    Ben Rhouma S; H'sairi M; Adbi H; Binous MY; Nouira Y; Ben Raies N; Mosbah AT; Horchani A
    Tunis Med; 2015 Mar; 93(3):164-9. PubMed ID: 26367405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of alfuzosin on sexual function in Taiwanese men with benign prostatic hyperplasia.
    Hwang TI; Chu SH; Lin MS; Chen CS; Lee LM; Chang HC; Yeh SD; Chen WH; Chiang PH
    Kaohsiung J Med Sci; 2012 Aug; 28(8):429-34. PubMed ID: 22892164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Rosen RC; Fitzpatrick JM;
    BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.
    Elhilali M; Emberton M; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Alcaraz A; Vallancien G;
    BJU Int; 2006 Mar; 97(3):513-9. PubMed ID: 16469018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia.
    Rosen R; Seftel A; Roehrborn CG
    Int J Impot Res; 2007; 19(5):480-5. PubMed ID: 17717526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.
    Nickel JC; Elhilali M; Emberton M; Vallancien G;
    BJU Int; 2006 Jun; 97(6):1242-6. PubMed ID: 16686719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia.
    Manjunatha R; Pundarikaksha HP; Madhusudhana HR; Amarkumar J; Hanumantharaju BK
    Indian J Pharmacol; 2016; 48(2):134-40. PubMed ID: 27127315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
    Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
    BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.
    van Moorselaar RJ; Hartung R; Emberton M; Harving N; Matzkin H; Elhilali M; Alcaraz A; Vallancien G;
    BJU Int; 2005 Mar; 95(4):603-8. PubMed ID: 15705088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
    Kaplan SA; Gonzalez RR; Te AE
    Eur Urol; 2007 Jun; 51(6):1717-23. PubMed ID: 17258855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexuality and the management of BPH with alfuzosin (SAMBA) trial.
    Chung BH; Lee JY; Kim CI; Kim CS; Oh CY; Lee SW; Lee JS; Yoo SJ
    Int J Impot Res; 2009; 21(1):68-73. PubMed ID: 19078970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.
    Yokoyama T; Hara R; Fukumoto K; Fujii T; Jo Y; Miyaji Y; Nagai A; Sone A
    Int J Urol; 2011 Mar; 18(3):225-30. PubMed ID: 21272091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry.
    Rosen RC; Wei JT; Althof SE; Seftel AD; Miner M; Perelman MA;
    Urology; 2009 Mar; 73(3):562-6. PubMed ID: 19167031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift.
    McVary KT; Gange SN; Shore ND; Bolton DM; Cowan BE; Brown BT; Te AE; Chin PT; Rukstalis DB; Roehrborn CG;
    J Sex Med; 2014 Jan; 11(1):279-87. PubMed ID: 24119101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.